FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

17598911000001103: Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Aug 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60696001000001113 Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60696101000001114 Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Is a Lansoprazole 15mg orodispersible gastro-resistant tablets true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has specific active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Is a Zoton FasTab true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) 28 tablet Has AMP True Zoton FasTab 15mg (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start